In our discussions with the data holders, QuintilesIMS, it hasn't been really so much pushback as a dialogue around what data is available and how we could receive that data.
I would just like to put out a general statement there that the data that we're requesting does allow for some flexibility around sensitivities. Right now we are moving forward with applying a Quebec formulary, but there would be potential to actually use a different formulary, so I just thought I'd add that.